JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$761M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$735M |
| 3 |
Zimmer Biomet
ZBH
|
+$542M |
| 4 |
Amazon
AMZN
|
+$439M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$438M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.01B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.11B |
| 3 |
AABA
Altaba Inc
AABA
|
+$699M |
| 4 |
TJX Companies
TJX
|
+$682M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 22.01% |
| 2 | Financials | 14.82% |
| 3 | Technology | 12.49% |
| 4 | Healthcare | 9.61% |
| 5 | Consumer Discretionary | 8.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
EBIX
3876
DELISTED
Ebix Inc
EBIX
| $521K | ﹤0.01% |
6,580
+5,578
| +557% | +$405K |
2016 Q4
4 quarters
|
|
3877
Eagle Bancorp
EGBN
$860M
| $520K | ﹤0.01% |
+8,990
| New | +$576K |
2017 Q4
0 quarters
|
|
|
ZAYO
3878
DELISTED
Zayo Group Holdings, Inc.
ZAYO
| $519K | ﹤0.01% |
14,113
+6,142
| +77% | +$217K |
2014 Q4
12 quarters
|
|
3879
Brookdale Senior Living
BKD
$2.59B
| $518K | ﹤0.01% |
53,413
+107
| +0.2% | +$1.09K |
2013 Q2
18 quarters
|
|
|
BSCI
3880
DELISTED
Invesco BulletShares 2018 Corporate Bond ETF
BSCI
| $517K | ﹤0.01% |
24,500
-21,101
| -46% | -$446K |
2015 Q4
8 quarters
|
|
3881
Donnelley Financial Solutions
DFIN
$1.17B
| $513K | ﹤0.01% |
26,323
+7,314
| +38% | +$149K |
2016 Q4
4 quarters
|
|
3882
Cass Information Systems
CASS
$688M
| $512K | ﹤0.01% |
10,570
-3,430
| -25% | -$171K |
2016 Q4
4 quarters
|
|
3883
Hingham Institution for Saving
HIFS
$624M
| $510K | ﹤0.01% |
2,460
+739
| +43% | +$149K |
2016 Q3
5 quarters
|
|
3884
ProShares MSCI Emerging Markets Dividend Growers ETF
EMDV
$7.11M
| $509K | ﹤0.01% |
+8,686
| New | +$482K |
2017 Q4
0 quarters
|
|
3885
Pricesmart
PSMT
$5.17B
| $509K | ﹤0.01% |
5,911
+5,080
| +611% | +$434K |
2015 Q4
8 quarters
|
|
3886
United States Lime & Minerals
USLM
$3.19B
| $508K | ﹤0.01% |
32,950
+25,845
| +364% | +$446K |
2016 Q4
4 quarters
|
|
|
LBAI
3887
DELISTED
Lakeland Bancorp Inc
LBAI
| $508K | ﹤0.01% |
26,446
+23,203
| +715% | +$470K |
2013 Q2
18 quarters
|
|
3888
Turkcell
TKC
$4.37B
| $507K | ﹤0.01% |
49,650
+44,930
| +952% | +$422K |
2017 Q3
1 quarter
|
|
|
EWRM
3889
DELISTED
GUGGENHEIM RUSSELL MIDCAP EQUAL WEIGHT ETF
EWRM
| $504K | ﹤0.01% |
7,843
+127
| +2% | +$8.16K |
2013 Q4
16 quarters
|
|
3890
Bank of Marin Bancorp
BMRC
$441M
| $503K | ﹤0.01% |
14,788
+2,834
| +24% | +$97.8K |
2014 Q1
15 quarters
|
|
|
MTGE
3891
DELISTED
MTGE Investment Corp. Common Stock
MTGE
| $502K | ﹤0.01% |
27,093
-25,768
| -49% | -$483K |
2013 Q2
18 quarters
|
|
|
TOUR
3892
Tuniu
TOUR
$54.1M
| $497K | ﹤0.01% |
6,478
-22,360
| -78% | -$1.75M |
2015 Q3
9 quarters
|
|
3893
MacroGenics
MGNX
$229M
| $496K | ﹤0.01% |
26,084
+6,609
| +34% | +$123K |
2013 Q4
16 quarters
|
|
|
BOJA
3894
DELISTED
Bojangles', Inc. Common Stock
BOJA
| $495K | ﹤0.01% |
+41,894
| New | +$529K |
2017 Q4
0 quarters
|
|
|
AXDX
3895
DELISTED
Accelerate Diagnostics
AXDX
| $494K | ﹤0.01% |
+1,886
| New | +$442K |
2017 Q4
0 quarters
|
|
|
CASC
3896
DELISTED
Cascadian Therapeutics, Inc.
CASC
| $493K | ﹤0.01% |
133,328
+43,915
| +49% | +$180K |
2017 Q1
3 quarters
|
|
3897
State Street SPDR S&P Capital Markets ETF
KCE
$515M
| $492K | ﹤0.01% |
+8,498
| New | +$467K |
2017 Q4
0 quarters
|
|
3898
Nomura Holdings
NMR
$28.5B
| $492K | ﹤0.01% |
84,525
+40,134
| +90% | +$232K |
2013 Q2
18 quarters
|
|
|
FSNN
3899
DELISTED
Fusion Connect, Inc. Common Stock
FSNN
| $491K | ﹤0.01% |
87,205
+46,938
| +117% | +$218K |
2017 Q3
1 quarter
|
|
3900
iShares US Consumer Discretionary ETF
IYC
$1.17B
| $490K | ﹤0.01% |
10,936
+1,220
| +13% | +$51.9K |
2013 Q2
18 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2017 Portfolio in Review
As of Q4 2017, JP Morgan Chase held 5,783 positions worth $475B, up 4.7% from $453B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q4 2017 filing shows 812 new, 2,513 increased, 1,655 reduced and 342 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.01B.
By sector, the portfolio is most concentrated in Miscellaneous at 22% of assets, down from 24% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M.
- JP Morgan Chase added most to Johnson & Johnson in Q4 2017, an estimated $761M increase.
- JP Morgan Chase's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.01B.
- JP Morgan Chase fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $275M.
- JP Morgan Chase's ten largest holdings make up 18% of its $475B portfolio in Q4 2017.
- JP Morgan Chase opened 812 new positions and closed 342 in Q4 2017.
- JP Morgan Chase's portfolio value rose 4.7% quarter-over-quarter to $475B.
Based on JP Morgan Chase's 13F filing for Q4 2017, filed 13 Feb 2018.